Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Julien Peron
Improved Androgen Receptor Splice Variant 7 Detection Using a Highly Sensitive Assay to Predict Resistance to Abiraterone or Enzalutamide in Metastatic Prostate Cancer Patients
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
Related publications
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Androgen Receptor Splice Variant-7 Expression Emerges With Castration Resistance in Prostate Cancer
Journal of Clinical Investigation
Medicine
Pd28-04 Detection of Androgen Receptor Variant 7 (Ar-V7) in Whole Blood Rna of Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Patients Treated With Abiraterone Acetate (Abi)
Journal of Urology
Urology
Branched Chain RNA in Situ Hybridization for Androgen Receptor Splice Variant AR-V7 as a Prognostic Biomarker for Metastatic Castration-Sensitive Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Collateral Resistance to Taxanes in Enzalutamide-Resistant Prostate Cancer Through Aberrant Androgen Receptor and Its Variants
Cancer Science
Cancer Research
Medicine
Oncology
Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients With Oligo-Progression During Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy
Klinicka Onkologie
Oncology
Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer
Cancer Research
Cancer Research
Oncology
Abiraterone Acetate for Metastatic Prostate Cancer in Patients With Suboptimal Biochemical Response to Hormone Induction
JAMA Oncology
Cancer Research
Oncology
